{"id":"preservative-free-artificial-tear","safety":{"commonSideEffects":[{"rate":null,"effect":"Transient blurred vision"},{"rate":null,"effect":"Mild ocular irritation"},{"rate":null,"effect":"Allergic reaction (rare)"}]},"_chembl":null,"_dailymed":{"setId":"4a08e9f4-44b3-9285-e063-6294a90a02f7","title":"EXOVISSE PRESERVATIVE-FREE ARTIFICIAL TEARS (LUBRICANT EYE GEL DROPS) GEL [YD BIO USA, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This product mimics the composition and function of natural tears to provide moisture and protection to the cornea and conjunctiva. By eliminating preservatives, it reduces the risk of ocular irritation and toxicity associated with preservative agents, making it suitable for frequent use and sensitive eyes. The formulation helps restore tear film stability and reduce symptoms of dry eye disease.","oneSentence":"Preservative-free artificial tears lubricate and protect the ocular surface by supplementing natural tear film.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T02:06:03.469Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dry eye disease / Keratoconjunctivitis sicca"},{"name":"Ocular surface protection and lubrication"}]},"trialDetails":[{"nctId":"NCT07243275","phase":"PHASE4","title":"SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease","status":"RECRUITING","sponsor":"Indiana University","startDate":"2026-02-18","conditions":"Dry Eye Disease (DED)","enrollment":260},{"nctId":"NCT06544694","phase":"PHASE3","title":"A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2024-10-08","conditions":"Dry Eye Disease","enrollment":80},{"nctId":"NCT06660290","phase":"PHASE3","title":"A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2025-01-15","conditions":"Dry Eye Disease","enrollment":55},{"nctId":"NCT07224529","phase":"PHASE4","title":"Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-04-01","conditions":"Meibomian Gland Dysfunction (MGD)","enrollment":48},{"nctId":"NCT07469865","phase":"NA","title":"Efficacy and Safety of 20% and 100% Autologous Serum Eye Drops in Patients With Severe Dry Eye Disease (AST)","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2021-11-30","conditions":"Dry Eye Disease","enrollment":46},{"nctId":"NCT07413172","phase":"PHASE2","title":"Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye","status":"NOT_YET_RECRUITING","sponsor":"University of Miami","startDate":"2026-03","conditions":"Dry Eye, Eye Diseases, Eyes Dry Chronic","enrollment":20},{"nctId":"NCT04505566","phase":"PHASE1","title":"INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stephen J. Kim, MD","startDate":"2020-11-09","conditions":"Diabetic Retinopathy","enrollment":164},{"nctId":"NCT05106127","phase":"PHASE2","title":"Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem","status":"NOT_YET_RECRUITING","sponsor":"Evergreen Therapeutics, Inc.","startDate":"2026-08","conditions":"Advanced Endometrial Cancer","enrollment":28},{"nctId":"NCT07181668","phase":"NA","title":"Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients Undergoing Femto-Lasik Surgery","status":"COMPLETED","sponsor":"Grigore T. Popa University of Medicine and Pharmacy","startDate":"2024-08-10","conditions":"Dry Eye, Meibomian Gland Dysfunction (Disorder), Ocular Surface Disease","enrollment":61},{"nctId":"NCT04125134","phase":"PHASE4","title":"Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests","status":"TERMINATED","sponsor":"Tufts Medical Center","startDate":"2019-10-03","conditions":"Dry Eye","enrollment":36},{"nctId":"NCT05902364","phase":"NA","title":"Systane® Ultra Preservative Free Lubricant Eye Drops","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2023-10-28","conditions":"Dry Eye","enrollment":69},{"nctId":"NCT07064187","phase":"PHASE4","title":"Evaluate The Improvement In Symptoms Of Patients Using Cationorm After Pterygium Surgery","status":"COMPLETED","sponsor":"Nguyen Viet Giap","startDate":"2022-06-15","conditions":"Ocular Discomfort","enrollment":100},{"nctId":"NCT07090044","phase":"PHASE4","title":"Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period","status":"COMPLETED","sponsor":"Retina Research Institute, LLC","startDate":"2021-08-20","conditions":"Vein Occlusion, Macular Degeneration Choroidal Neovascularization, Macular Edema","enrollment":77},{"nctId":"NCT05682547","phase":"NA","title":"Diquafosol vs Hyaluronic Acid for Diabetic Dry Eye","status":"COMPLETED","sponsor":"He Eye Hospital","startDate":"2022-12-01","conditions":"Diabetic Eye Problems","enrollment":99},{"nctId":"NCT06655441","phase":"PHASE4","title":"The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function","status":"NOT_YET_RECRUITING","sponsor":"Southern California College of Optometry at Marshall B. Ketchum University","startDate":"2025-09-01","conditions":"Dry Eye Disease (DED)","enrollment":30},{"nctId":"NCT06989827","phase":"NA","title":"Impact of DED on the Accuracy of Preoperative Keratometry Values in the Calculation of IOL Power for Cataract Surgery.","status":"NOT_YET_RECRUITING","sponsor":"University Hospital Sestre Milosrdnice","startDate":"2025-06-02","conditions":"Dry Eye Disease (DED), Cataract","enrollment":100},{"nctId":"NCT05814367","phase":"PHASE2","title":"Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of Investigational Lubricating Eye Drops","status":"COMPLETED","sponsor":"Johnson & Johnson Vision Care, Inc.","startDate":"2023-04-06","conditions":"Visual Acuity","enrollment":46},{"nctId":"NCT05661851","phase":"PHASE2","title":"Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients","status":"COMPLETED","sponsor":"Johnson & Johnson Vision Care, Inc.","startDate":"2023-02-23","conditions":"Dry Eye","enrollment":121},{"nctId":"NCT06921525","phase":"PHASE1, PHASE2","title":"Comparing Efficacy of Tea Tree Oil Versus Topical Azithromycin in Treating Dry Eye","status":"NOT_YET_RECRUITING","sponsor":"Ehab Mohamed Elsayed Mohamed Saad","startDate":"2025-04-01","conditions":"Dry Eye","enrollment":44},{"nctId":"NCT05932225","phase":"NA","title":"Systane® Complete Preservative Free Lubricant Eye Drops","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2023-08-18","conditions":"Dry Eye","enrollment":71},{"nctId":"NCT06163105","phase":"NA","title":"The Effect of Gland Expression on the Regeneration of Meibomian Gland","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2024-10-03","conditions":"Meibomian Gland Dysfunction","enrollment":64},{"nctId":"NCT05705518","phase":"PHASE4","title":"Artificial Tears, Tear Lipids and Tear Film Dynamics","status":"COMPLETED","sponsor":"University of California, Berkeley","startDate":"2023-01-30","conditions":"Dry Eye","enrollment":81},{"nctId":"NCT06860659","phase":"PHASE4","title":"Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient with Moderate to Severe Dry Eye","status":"ENROLLING_BY_INVITATION","sponsor":"Department of Medical Services Ministry of Public Health of Thailand","startDate":"2024-09-01","conditions":"Dry Eye Disease (DED), Tear Break-Up Time, Tear Disorder","enrollment":84},{"nctId":"NCT05832996","phase":"PHASE4","title":"Cool vs Room-temperature Artificial Tears","status":"COMPLETED","sponsor":"University of Iowa","startDate":"2022-03-01","conditions":"Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis), Central Retinal Vein Occlusion With Macular Edema, Exudative Age-Related Macular Degeneration, Unspecified Eye","enrollment":124},{"nctId":"NCT06671041","phase":"PHASE4","title":"Treating Lid Wiper Epitheliopathy","status":"COMPLETED","sponsor":"Southern College of Optometry","startDate":"2024-05-27","conditions":"Dry Eye, Visual Acuity","enrollment":52},{"nctId":"NCT06822608","phase":"PHASE4","title":"Evaluation of Dexpanthenol and Hyaluronic Acid Eye Drops on Corneal Epithelialization After Trans Epithelial PRK","status":"NOT_YET_RECRUITING","sponsor":"National and Kapodistrian University of Athens","startDate":"2025-02","conditions":"Corneal Epithelial Wound Healing","enrollment":68},{"nctId":"NCT06798025","phase":"NA","title":"Three Different Modalities for Treatment of Inflammatory Punctal Stenosis","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-07-20","conditions":"Modalities, Treatment, Inflammatory Punctal Stenosis","enrollment":60},{"nctId":"NCT04604834","phase":"NA","title":"Autologous Platelet-rich Plasma (APRP) in the Treatment of Neurotrophic Keratopathy","status":"RECRUITING","sponsor":"Universidad Autonoma de Nuevo Leon","startDate":"2020-11-01","conditions":"Neurotrophic Keratopathy","enrollment":39},{"nctId":"NCT06221345","phase":"PHASE4","title":"Hyaluronic Acid-containing Artificial Tears in Post-cataract Surgery Dry Eye Disease","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2021-12-07","conditions":"Dry Eye Disease, Cataract","enrollment":70},{"nctId":"NCT04327999","phase":"PHASE2","title":"Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System","status":"TERMINATED","sponsor":"Vanderbilt-Ingram Cancer Center","startDate":"2020-10-05","conditions":"Thyroid Carcinoma, Radioactive Iodine Level","enrollment":9},{"nctId":"NCT04515329","phase":"PHASE4","title":"Tear Film Markers in Dry Eye Syndrome","status":"WITHDRAWN","sponsor":"Vishal Jhanji","startDate":"2023-12-08","conditions":"Dry Eye","enrollment":""},{"nctId":"NCT04465071","phase":"NA","title":"Lubricating Eye Drops After Routine Cataract Surgery","status":"COMPLETED","sponsor":"Guy's and St Thomas' NHS Foundation Trust","startDate":"2020-02-24","conditions":"Dry Eye, Cataract","enrollment":79},{"nctId":"NCT05618730","phase":"PHASE1","title":"Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B","status":"UNKNOWN","sponsor":"Eximore Ltd.","startDate":"2022-09-29","conditions":"Dry Eye, Keratoconjunctivitis Sicca, Ocular Inflammation","enrollment":20},{"nctId":"NCT05660681","phase":"NA","title":"Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops","status":"COMPLETED","sponsor":"Calm Water Therapeutics LLC","startDate":"2022-12-12","conditions":"Dry Eye Disease","enrollment":34},{"nctId":"NCT02340962","phase":"PHASE2","title":"Evaluate the Efficacy and Safety of TG-2349 in Subjects With Hepatitis C Infection","status":"COMPLETED","sponsor":"TaiGen Biotechnology Co., Ltd.","startDate":"2015-05","conditions":"Hepatitis C, Chronic","enrollment":25},{"nctId":"NCT05940376","phase":"","title":"Topical Insulin in Neurotrophic Keratopathy After Diabetic Vitrectomy","status":"UNKNOWN","sponsor":"Benha University","startDate":"2023-07-15","conditions":"Corneal Ulcer, Neurotrophic Corneal Ulcer, Diabetes Mellitus","enrollment":30},{"nctId":"NCT04850313","phase":"NA","title":"Evaluating the Use of ProKera Plus® in the Management of Bacterial Corneal Ulcers","status":"TERMINATED","sponsor":"University of Arkansas","startDate":"2021-11-09","conditions":"Bacterial Corneal Ulcer","enrollment":3},{"nctId":"NCT05733741","phase":"PHASE4","title":"Preservative-free Topical Anesthetics for Post-PRK Pain","status":"COMPLETED","sponsor":"Assiut University","startDate":"2023-01-30","conditions":"Myopia","enrollment":70},{"nctId":"NCT05292755","phase":"PHASE4","title":"Effects of Carboxymethylcellulose Artificial Tears on the Eye Microbiome","status":"COMPLETED","sponsor":"University of Florida","startDate":"2022-04-22","conditions":"Dry Eye Syndromes","enrollment":80},{"nctId":"NCT04980144","phase":"NA","title":"Diquafosol Ophthalmic Solution for Dry Eye Symptoms","status":"UNKNOWN","sponsor":"He Eye Hospital","startDate":"2023-03-03","conditions":"Diabetic Eye Problems","enrollment":101},{"nctId":"NCT04837807","phase":"PHASE4","title":"Digital Device Users Who Are Treated With Systane Hydration PF","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2021-08-18","conditions":"Dry Eye","enrollment":30},{"nctId":"NCT05536661","phase":"NA","title":"Impact of Tear Substitute Use on Dry Eye in Gamers.","status":"COMPLETED","sponsor":"Laboratorios Thea, Spain","startDate":"2019-07-04","conditions":"Evaporative Dry Eye","enrollment":56},{"nctId":"NCT04673604","phase":"NA","title":"From Preserved, to Preservative-free Cyclosporine 0.1% Enhanced Triple Glaucoma Therapy","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2018-05-06","conditions":"Glaucoma, Ocular Surface Disease","enrollment":42},{"nctId":"NCT05433428","phase":"PHASE4","title":"Metabolomic Profile in Dry Eye Syndrome Patients.","status":"UNKNOWN","sponsor":"Ifocus Oyeklinikk","startDate":"2020-08-03","conditions":"Dry Eye Syndromes, Cataract","enrollment":250},{"nctId":"NCT05145959","phase":"NA","title":"Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis","status":"UNKNOWN","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2021-12-01","conditions":"Stevens-Johnson Syndrome, Toxic Epidermal Necrolyses, Ocular Surface Disease","enrollment":30},{"nctId":"NCT05028907","phase":"PHASE4","title":"Evaluation of Lacrimal Punctal Changes by Anterior Segment Optical Coherence Tomography AS-OCT After Topical Combined Antibiotics and Steroids Treatment in Cases of Inflammatory Punctual Stenosis","status":"COMPLETED","sponsor":"Sohag University","startDate":"2020-11-15","conditions":"Ophthalmopathy , Lacrimal System","enrollment":64},{"nctId":"NCT00748059","phase":"PHASE1","title":"The Pathophysiology of Orthostatic Hypotension","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"1996-12","conditions":"Autonomic Nervous System Diseases, Orthostatic Hypotension, Dopamine Beta-Hydroxylase Deficiency","enrollment":10},{"nctId":"NCT04637633","phase":"PHASE2, PHASE3","title":"Topical Cyclosporine-A for Management of Epiphora","status":"COMPLETED","sponsor":"Farwaniya Hospital","startDate":"2020-08-15","conditions":"Epiphora","enrollment":12},{"nctId":"NCT04140422","phase":"NA","title":"Eye Drops for Early Morning-Associated Corneal Swelling of the Cornea","status":"COMPLETED","sponsor":"University Eye Hospital, Freiburg","startDate":"2019-10-24","conditions":"Fuchs' Endothelial Dystrophy","enrollment":68},{"nctId":"NCT03569202","phase":"NA","title":"Piiloset Trehalose Emulsion Eye Drop Study in Moderate or Severe Dry Eye","status":"COMPLETED","sponsor":"Kuopio University Hospital","startDate":"2018-05-21","conditions":"Dry Eye Syndrome","enrollment":64},{"nctId":"NCT03223909","phase":"PHASE4","title":"Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2016-10-13","conditions":"Dry Eye Syndrome","enrollment":326},{"nctId":"NCT04131335","phase":"NA","title":"Use of Prophylactic Lubricating Drops After Cataract Surgery","status":"UNKNOWN","sponsor":"Guy's and St Thomas' NHS Foundation Trust","startDate":"2019-10-14","conditions":"Dry Eye, Cataract Surgery, Patient Related Outcome Measures","enrollment":168},{"nctId":"NCT03888183","phase":"PHASE4","title":"Effect of Preservative-free Low-dose Hyaluronic Acid-containing Salt Solution on Dry Eye Disease","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2019-04-17","conditions":"Dry Eye","enrollment":334},{"nctId":"NCT01817582","phase":"PHASE2","title":"Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2013-05-17","conditions":"Keratoconjunctivitis Sicca","enrollment":102},{"nctId":"NCT03524157","phase":"PHASE1","title":"Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy Subjects","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2017-07-17","conditions":"Dry Eye Syndromes, Lubricant Allergy, Tear Disorder","enrollment":30},{"nctId":"NCT03918590","phase":"PHASE4","title":"Post Intravitreal Injection Topical NSAID vs. Patching","status":"UNKNOWN","sponsor":"The New York Eye & Ear Infirmary","startDate":"2018-12-03","conditions":"Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion","enrollment":60},{"nctId":"NCT01459588","phase":"PHASE3","title":"Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease","status":"COMPLETED","sponsor":"Allergan","startDate":"2011-10-01","conditions":"Dry Eye Syndromes","enrollment":315},{"nctId":"NCT01533376","phase":"PHASE1","title":"Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol","status":"TERMINATED","sponsor":"Wills Eye","startDate":"2012-02","conditions":"Sturge Weber Syndrome, Port-wine Mark","enrollment":3},{"nctId":"NCT02420834","phase":"NA","title":"Dry Eye Treatment With Artificial Tears","status":"COMPLETED","sponsor":"Aston University","startDate":"2015-04","conditions":"Dry Eye","enrollment":50},{"nctId":"NCT02417116","phase":"NA","title":"Tear Osmolarity Clinical Utility in Dry Eye Disease","status":"COMPLETED","sponsor":"Aston University","startDate":"2015-06","conditions":"Dry Eye","enrollment":120},{"nctId":"NCT03666884","phase":"PHASE4","title":"The Comparison of 50% AS Versus PFAT+ 0.05 % COE in Severe Dry Eye Syndrome","status":"COMPLETED","sponsor":"Seref istek","startDate":"2015-10-10","conditions":"Dry Eye Syndrome","enrollment":36},{"nctId":"NCT02908282","phase":"NA","title":"Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry Eye","status":"COMPLETED","sponsor":"TRB Chemedica AG","startDate":"2016-10","conditions":"Dry Eye Syndromes","enrollment":81},{"nctId":"NCT03597867","phase":"PHASE3","title":"PGE2 Levels in Patient Treated With NSAIDs","status":"COMPLETED","sponsor":"University of Trieste","startDate":"2018-04-25","conditions":"Ocular Inflammation","enrollment":104},{"nctId":"NCT02470429","phase":"NA","title":"Evaluation of Clinical Outcomes After the Use of SYSTANE® HYDRATION","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2015-07-17","conditions":"Dry Eye","enrollment":114},{"nctId":"NCT01569191","phase":"PHASE4","title":"Non-Pharmaceutical Treatment of Seasonal Allergic Conjunctivitis","status":"COMPLETED","sponsor":"Aston University","startDate":"2012-03","conditions":"Hypersensitivity","enrollment":18},{"nctId":"NCT02752763","phase":"PHASE4","title":"Comparison of Autologous Serum Versus Preservative Free Artificial Tear","status":"COMPLETED","sponsor":"Niğde State Hospital","startDate":"2015-10","conditions":"Dry Eye","enrollment":24},{"nctId":"NCT01812044","phase":"NA","title":"Postoperative Subtenons Anesthesia for Postoperative Pain in Pediatric Strabismus Surgery","status":"COMPLETED","sponsor":"Duke University","startDate":"2013-03","conditions":"Strabismus","enrollment":57},{"nctId":"NCT01664949","phase":"PHASE3","title":"A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease","status":"COMPLETED","sponsor":"Allergan","startDate":"2013-01","conditions":"Dry Eye Disease","enrollment":460},{"nctId":"NCT01799863","phase":"PHASE2, PHASE3","title":"Artificial Tears Versus Preservative Free Ketorolac Trometamol 0.45% for Acute Viral Conjunctivitis","status":"COMPLETED","sponsor":"Fundação Altino Ventura","startDate":"2012-06","conditions":"Conjunctivitis, Viral","enrollment":50},{"nctId":"NCT02014922","phase":"PHASE4","title":"A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products (DUNLIN)","status":"COMPLETED","sponsor":"University of Waterloo","startDate":"2013-12","conditions":"Dry Eye Syndromes","enrollment":33},{"nctId":"NCT01280110","phase":"PHASE4","title":"The Effects of BAK on the Blood Aqueous Barrier of Pseudophakic Patients","status":"COMPLETED","sponsor":"University of Campinas, Brazil","startDate":"2011-03","conditions":"Dry Eye Syndromes","enrollment":44},{"nctId":"NCT01363414","phase":"NA","title":"Sodium Hyaluronate and Wavefront Aberrations in Dry Eyes","status":"COMPLETED","sponsor":"Ramathibodi Hospital","startDate":"2007-01","conditions":"Dry Eye","enrollment":50},{"nctId":"NCT01105221","phase":"PHASE3","title":"Acupuncture for Dry Eye","status":"COMPLETED","sponsor":"Korea Institute of Oriental Medicine","startDate":"2010-04","conditions":"Dry Eye","enrollment":150},{"nctId":"NCT01075347","phase":"PHASE1","title":"Topical Autologous Serum Application for the Treatment of Corneal Epithelium Defect After Ocular Surgeries","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2007-03","conditions":"Corneal Epithelial Defect, Diabetic Retinopathy, Penetrating Keratoplasty","enrollment":165}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"DRUG INEFFECTIVE"},{"count":1,"reaction":"EYE PAIN"},{"count":1,"reaction":"PRODUCT ADMINISTRATION ERROR"}],"_approvalHistory":[],"publicationCount":23,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Optive UD®, Allergan, Irvine, USA"],"phase":"marketed","status":"active","brandName":"Preservative free artificial tear","genericName":"Preservative free artificial tear","companyName":"Fundação Altino Ventura","companyId":"funda-o-altino-ventura","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Preservative-free artificial tears lubricate and protect the ocular surface by supplementing natural tear film. Used for Dry eye disease / Keratoconjunctivitis sicca, Ocular surface protection and lubrication.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}